Quantitative trifluoromethylation of carbonyl-containing lignin model compounds
作者:B.C. Ahvazi、D.S. Argyropoulos
DOI:10.1016/0022-1139(96)03431-8
日期:1996.6
lignin model compounds was made possible by using Ruppert' s reagent in the presence of tetramethylammonium fluoride (TMAF), followed by hydrolysis with aqueous HF. These studies demonstrate that such a method can quantitatively convert carbonylgroups to the CF3-containing compounds, thus qualifying the procedure as a potential analytical tool for the determination of carbonylgroups in lignins.
<sup>19</sup>F Nuclear Magnetic Resonance Spectroscopy for the Elucidation of Carbonyl Groups in Lignins. 1. Model Compounds
作者:Behzad C. Ahvazi、Dimitris S. Argyropoulos
DOI:10.1021/jf960154r
日期:1996.1.1
A new method for the detection of different classes of carbonyl groups in a series of carbonyl-containing lignin-like model compounds has been developed. The method is based on the selective fluoride-induced trifluoromethylation of carbonyl groups with (trifluoromethyl)trimethylsilane (TMS-CF3) in the presence of tetramethylammonium fluoride (TMAF), followed by hydrolysis with aqueous HF or TMAF in the case of quinones. In this study a series of ketones, aldehydes, quinones, and dimeric-lignin model compounds were quantitatively trifluoromethylated followed by F-19 NMR spectral analyses of the resulting fluorine-containing derivatives, allowing for a thorough understanding of their structure/F-19 chemical shift relationships. These studies have shown that the F-19-NMR chemical shifts of the trifluoromethyl groups vary significantly and consistently for various classes of carbonyl groups which may be present in complex lignocellulosic materials. These studies are to form the basis for the development of a novel and sensitive method that can be used to obtain quantitative information on the various carbonyl groups present in such materials.
LEUKOTRIENE SYNTHESIS INHIBITORS
申请人:Naegis Pharmaceuticals Inc.
公开号:EP3908278A1
公开(公告)日:2021-11-17
[EN] LEUKOTRIENE SYNTHESIS INHIBITORS<br/>[FR] INHIBITEURS DE LA SYNTHÈSE DES LEUCOTRIÈNES
申请人:NAEGIS PHARMACEUTICALS INC
公开号:WO2020146822A1
公开(公告)日:2020-07-16
Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.